Literature DB >> 26379026

Erratum: Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia.

Florian Grebien, Masoud Vedadi, Matthäus Getlik, Roberto Giambruno, Amit Grover, Roberto Avellino, Anna Skucha, Sarah Vittori, Ekaterina Kuznetsova, David Smil, Dalia Barsyte-Lovejoy, Fengling Li, Gennadiy Poda, Matthieu Schapira, Hong Wu, Aiping Dong, Guillermo Senisterra, Alexey Stukalov, Kilian V M Huber, Andreas Schönegger, Richard Marcellus, Martin Bilban, Christoph Bock, Peter J Brown, Johannes Zuber, Keiryn L Bennett, Rima Al-Awar, Ruud Delwel, Claus Nerlov, Cheryl H Arrowsmith, Giulio Superti-Furga.   

Abstract

Entities:  

Year:  2015        PMID： 26379026     DOI： 10.1038/nchembio1015-815b

Source DB:  PubMed          Journal:  Nat Chem Biol        ISSN： 1552-4450            Impact factor:   15.040


× No keyword cloud information.
  1 in total

1.  Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia.

Authors:  Florian Grebien; Masoud Vedadi; Matthäus Getlik; Cheryl H Arrowsmith; Giulio Superti-Furga; Roberto Giambruno; Amit Grover; Roberto Avellino; Anna Skucha; Sarah Vittori; Ekaterina Kuznetsova; David Smil; Dalia Barsyte-Lovejoy; Fengling Li; Gennadiy Poda; Matthieu Schapira; Hong Wu; Aiping Dong; Guillermo Senisterra; Alexey Stukalov; Kilian V M Huber; Andreas Schönegger; Richard Marcellus; Martin Bilban; Christoph Bock; Peter J Brown; Johannes Zuber; Keiryn L Bennett; Rima Al-Awar; Ruud Delwel; Claus Nerlov
Journal:  Nat Chem Biol       Date:  2015-07-13       Impact factor: 15.040
  1 in total
  1 in total

1.  Gain-of-function p53 mutants co-opt chromatin pathways to drive cancer growth.

Authors:  Jiajun Zhu; Morgan A Sammons; Greg Donahue; Zhixun Dou; Masoud Vedadi; Matthäus Getlik; Dalia Barsyte-Lovejoy; Rima Al-awar; Bryson W Katona; Ali Shilatifard; Jing Huang; Xianxin Hua; Cheryl H Arrowsmith; Shelley L Berger
Journal:  Nature       Date:  2015-09-02       Impact factor: 49.962
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.